Skip to content

APOTHEEK BLAASVELD: what changed

What changed

APOTHEEK BLAASVELD

BE 0474.976.930
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€471,434
2024 · €366,526+€104,908
Equity
€2.0m
2024 · €2.0m+€44,234
Cash
€688,990
2024 · €340,027+€348,963
Balance sheet total
€2.9m
2024 · €2.7m+€168,921

Largest movements

2024 to 2025
Assets
  • Cash +€348,963

    up €348,963 (+103%), from €340,027 to €688,990

    mainly Net result for the year (+€471,434) and Current investments (+€187,814)

  • Current investments -€187,814

    down €187,814 (-14.5%), from €1.3m to €1.1m

  • Tangible fixed assets -€43,687

    down €43,687 (-7.2%), from €609,605 to €565,918

Equity and liabilities
  • Other debts +€97,515

    up €97,515 (+16.6%), from €587,177 to €684,692

  • Reserves +€44,234

    up €44,234 (+2.3%), from €1.9m to €2.0m

Income statement
  • Gross operating margin +€82,788

    up €82,788 (+10.0%), from €830,670 to €913,458

  • Financial income +€56,347

    up €56,347 (+368%), from €15,297 to €71,644

  • Taxes +€37,432

    up €37,432 (+22.7%), from €164,694 to €202,126

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €366,526
Gross operating margin +€82,788
Staff costs -€3,892
Depreciation +€6,032
Other operating charges +€379
Financial income +€56,347
Financial charges +€686
Taxes -€37,432
Result 2025 €471,434
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€613,367
Investment +€162,797
Financing -€427,200
Cash 2024 €340,027
Net result for the year +€471,434
Depreciation +€68,704
Stocks and contracts -€13,291
Receivables within one year -€24,703
Deferred charges and accrued income -€13,464
Trade debts +€9,280
Tax, wage and social debts +€18,885
Other debts +€97,515
Accrued charges and deferred income -€993
Investment in fixed assets (net) -€25,017
Current investments +€187,814
Contributions, distributions and other -€427,200
Cash 2025 €688,990
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,696,077 €2,864,998 +€168,921 +6.3%
Fixed assets 21/28 €614,605 €570,918 -€43,687 -7.1%
Tangible fixed assets 22/27 €609,605 €565,918 -€43,687 -7.2%
Land and buildings 22 €407,190 €396,433 -€10,758 -2.6%
Plant, machinery and equipment 23 €153,225 €141,735 -€11,490 -7.5%
Furniture and vehicles 24 €49,190 €27,751 -€21,439 -43.6%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €2,081,472 €2,294,080 +€212,608 +10.2%
Stocks and contracts in progress 3 €320,428 €333,720 +€13,291 +4.1%
Stocks 30/36 €320,428 €333,720 +€13,291 +4.1%
Amounts receivable within one year 40/41 €121,885 €146,588 +€24,703 +20.3%
Trade receivables 40 €121,885 €146,588 +€24,703 +20.3%
Current investments 50/53 €1,293,331 €1,105,517 -€187,814 -14.5%
Cash at bank and in hand 54/58 €340,027 €688,990 +€348,963 +103%
Deferred charges and accrued income 490/1 €5,801 €19,265 +€13,464 +232%
Total equity and liabilities 10/49 €2,696,077 €2,864,998 +€168,921 +6.3%
Equity 10/15 €1,961,118 €2,005,352 +€44,234 +2.3%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,942,518 €1,986,752 +€44,234 +2.3%
Distributable reserves 133 €1,942,518 €1,986,752 +€44,234 +2.3%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €734,959 €859,646 +€124,687 +17.0%
Amounts payable within one year 42/48 €714,787 €840,467 +€125,680 +17.6%
Trade debts 44 €70,014 €79,295 +€9,280 +13.3%
Suppliers 440/4 €70,014 €79,295 +€9,280 +13.3%
Taxes, remuneration and social security 45 €57,595 €76,480 +€18,885 +32.8%
Taxes 450/3 €33,990 €47,414 +€13,425 +39.5%
Remuneration and social security 454/9 €23,605 €29,065 +€5,460 +23.1%
Other amounts payable 47/48 €587,177 €684,692 +€97,515 +16.6%
Accrued charges and deferred income 492/3 €20,172 €19,179 -€993 -4.9%
Remuneration, social security and pensions 62 €213,828 €217,720 +€3,892 +1.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €74,736 €68,704 -€6,032 -8.1%
Other operating charges 640/8 €868 €489 -€379 -43.7%
Gross operating margin 9900 €830,670 €913,458 +€82,788 +10.0%
Operating profit (loss) 9901 €541,237 €626,545 +€85,307 +15.8%
Financial income 75/76B €15,297 €71,644 +€56,347 +368%
Recurring financial income 75 €15,297 €71,644 +€56,347 +368%
Financial charges 65/66B €25,315 €24,629 -€686 -2.7%
Recurring financial charges 65 €25,315 €24,629 -€686 -2.7%
Profit (loss) for the period before taxes 9903 €531,219 €673,560 +€142,341 +26.8%
Income taxes 67/77 €164,694 €202,126 +€37,432 +22.7%
Profit (loss) for the period 9904 €366,526 €471,434 +€104,908 +28.6%
Transfer from tax-exempt reserves 789 €0 - =
Profit (loss) for the period to be appropriated 9905 €366,526 €471,434 +€104,908 +28.6%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.